vs
GE医疗（CCRN）与MARCUS CORP（MCS）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是MARCUS CORP的1.2倍（$236.8M vs $193.5M），MARCUS CORP同比增速更快（2.8% vs -23.6%），MARCUS CORP自由现金流更多（$26.4M vs $16.1M），过去两年MARCUS CORP的营收复合增速更高（18.2% vs -21.0%）
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
马库斯公司是一家美国企业，主营商业地产领域相关服务，业务覆盖美国与加拿大，提供商业地产经纪、按揭经纪、行业研究以及咨询服务，首创了由单一经纪公司独家代理房源挂牌的行业模式，目前在美加两国设有超过80家办公室，拥有员工超1800名。
CCRN vs MCS — 直观对比
营收规模更大
CCRN
是对方的1.2倍
$193.5M
营收增速更快
MCS
高出26.4%
-23.6%
自由现金流更多
MCS
多$10.3M
$16.1M
两年增速更快
MCS
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $236.8M | $193.5M |
| 净利润 | $-82.9M | — |
| 毛利率 | — | — |
| 营业利润率 | -30.2% | 0.9% |
| 净利率 | -35.0% | — |
| 营收同比 | -23.6% | 2.8% |
| 净利润同比 | -2109.7% | — |
| 每股收益（稀释后） | $-2.56 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCRNMCS
| Q4 25 | $236.8M | $193.5M | ||
| Q3 25 | $250.1M | $210.2M | ||
| Q2 25 | $274.1M | $206.0M | ||
| Q1 25 | $293.4M | $148.8M | ||
| Q4 24 | $309.9M | $188.3M | ||
| Q3 24 | $315.1M | $232.7M | ||
| Q2 24 | $339.8M | $176.0M | ||
| Q1 24 | $379.2M | $138.5M |
净利润CCRNMCS
| Q4 25 | $-82.9M | — | ||
| Q3 25 | $-4.8M | $16.2M | ||
| Q2 25 | $-6.7M | $7.3M | ||
| Q1 25 | $-490.0K | $-16.8M | ||
| Q4 24 | $-3.8M | $986.0K | ||
| Q3 24 | $2.6M | $23.3M | ||
| Q2 24 | $-16.1M | $-20.2M | ||
| Q1 24 | $2.7M | $-11.9M |
毛利率CCRNMCS
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
营业利润率CCRNMCS
| Q4 25 | -30.2% | 0.9% | ||
| Q3 25 | -2.4% | 10.8% | ||
| Q2 25 | -2.1% | 6.3% | ||
| Q1 25 | -0.3% | -13.7% | ||
| Q4 24 | -1.1% | -1.2% | ||
| Q3 24 | 0.9% | 14.1% | ||
| Q2 24 | -5.7% | 1.3% | ||
| Q1 24 | 0.8% | -12.0% |
净利率CCRNMCS
| Q4 25 | -35.0% | — | ||
| Q3 25 | -1.9% | 7.7% | ||
| Q2 25 | -2.4% | 3.6% | ||
| Q1 25 | -0.2% | -11.3% | ||
| Q4 24 | -1.2% | 0.5% | ||
| Q3 24 | 0.8% | 10.0% | ||
| Q2 24 | -4.7% | -11.5% | ||
| Q1 24 | 0.7% | -8.6% |
每股收益（稀释后）CCRNMCS
| Q4 25 | $-2.56 | — | ||
| Q3 25 | $-0.15 | — | ||
| Q2 25 | $-0.20 | — | ||
| Q1 25 | $-0.02 | — | ||
| Q4 24 | $-0.13 | — | ||
| Q3 24 | $0.08 | — | ||
| Q2 24 | $-0.47 | — | ||
| Q1 24 | $0.08 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $108.7M | $23.4M |
| 总债务越低越好 | — | $159.0M |
| 股东权益账面价值 | $322.8M | $457.4M |
| 总资产 | $449.0M | $1.0B |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资CCRNMCS
| Q4 25 | $108.7M | $23.4M | ||
| Q3 25 | $99.1M | $7.4M | ||
| Q2 25 | $81.2M | $14.9M | ||
| Q1 25 | $80.7M | $11.9M | ||
| Q4 24 | $81.6M | $40.8M | ||
| Q3 24 | $64.0M | $28.4M | ||
| Q2 24 | $69.6M | $32.8M | ||
| Q1 24 | $5.2M | $17.3M |
总债务CCRNMCS
| Q4 25 | — | $159.0M | ||
| Q3 25 | — | $162.0M | ||
| Q2 25 | — | $179.9M | ||
| Q1 25 | — | $198.9M | ||
| Q4 24 | — | $159.1M | ||
| Q3 24 | — | $173.1M | ||
| Q2 24 | — | $175.7M | ||
| Q1 24 | — | $169.8M |
股东权益CCRNMCS
| Q4 25 | $322.8M | $457.4M | ||
| Q3 25 | $408.1M | $454.3M | ||
| Q2 25 | $412.2M | $448.4M | ||
| Q1 25 | $418.2M | $441.8M | ||
| Q4 24 | $419.0M | $464.9M | ||
| Q3 24 | $424.7M | $462.3M | ||
| Q2 24 | $433.3M | $449.4M | ||
| Q1 24 | $462.4M | $459.3M |
总资产CCRNMCS
| Q4 25 | $449.0M | $1.0B | ||
| Q3 25 | $538.2M | $1.0B | ||
| Q2 25 | $553.8M | $1.0B | ||
| Q1 25 | $576.2M | $1.0B | ||
| Q4 24 | $589.3M | $1.0B | ||
| Q3 24 | $597.4M | $1.0B | ||
| Q2 24 | $602.9M | $1.1B | ||
| Q1 24 | $648.4M | $1.0B |
负债/权益比CCRNMCS
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.39× | ||
| Q1 24 | — | 0.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.2M | $48.8M |
| 自由现金流经营现金流 - 资本支出 | $16.1M | $26.4M |
| 自由现金流率自由现金流/营收 | 6.8% | 13.6% |
| 资本支出强度资本支出/营收 | 0.9% | 11.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.1M | $989.0K |
8季度趋势，按日历期对齐
经营现金流CCRNMCS
| Q4 25 | $18.2M | $48.8M | ||
| Q3 25 | $20.1M | $39.1M | ||
| Q2 25 | $4.2M | $31.6M | ||
| Q1 25 | $5.7M | $-35.3M | ||
| Q4 24 | $24.2M | $52.6M | ||
| Q3 24 | $7.5M | $30.5M | ||
| Q2 24 | $82.4M | $36.0M | ||
| Q1 24 | $6.0M | $-15.1M |
自由现金流CCRNMCS
| Q4 25 | $16.1M | $26.4M | ||
| Q3 25 | $17.9M | $18.2M | ||
| Q2 25 | $2.3M | $14.7M | ||
| Q1 25 | $3.8M | $-58.3M | ||
| Q4 24 | $21.7M | $27.1M | ||
| Q3 24 | $6.3M | $12.0M | ||
| Q2 24 | $79.6M | $16.1M | ||
| Q1 24 | $3.8M | $-30.5M |
自由现金流率CCRNMCS
| Q4 25 | 6.8% | 13.6% | ||
| Q3 25 | 7.2% | 8.7% | ||
| Q2 25 | 0.8% | 7.1% | ||
| Q1 25 | 1.3% | -39.2% | ||
| Q4 24 | 7.0% | 14.4% | ||
| Q3 24 | 2.0% | 5.2% | ||
| Q2 24 | 23.4% | 9.2% | ||
| Q1 24 | 1.0% | -22.0% |
资本支出强度CCRNMCS
| Q4 25 | 0.9% | 11.6% | ||
| Q3 25 | 0.9% | 9.9% | ||
| Q2 25 | 0.7% | 8.2% | ||
| Q1 25 | 0.6% | 15.5% | ||
| Q4 24 | 0.8% | 13.5% | ||
| Q3 24 | 0.4% | 7.9% | ||
| Q2 24 | 0.8% | 11.3% | ||
| Q1 24 | 0.6% | 11.1% |
现金转化率CCRNMCS
| Q4 25 | — | — | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | — | 4.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 53.31× | ||
| Q3 24 | 2.92× | 1.31× | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
MCS
| Theatres | $123.1M | 64% |
| Concessions | $51.0M | 26% |
| Food And Beverage | $21.2M | 11% |
